| ||||||||||||||
|
|
|||||||||||||


Departments of
*Anesthesiology and
Gynecology, Hotel-Dieu Hospital Paris, France
Address correspondence and reprint requests to Andrei Goldstein, MD, Department of Anesthesiology, Hotel-Dieu Hospital, 1 Place du Parvis Notre-Dame, 75181 Paris Cédex 04, France. Address e-mail to goldsteinandrei{at}yahoo.fr
We tested the hypothesis that local anesthetics instilled at the end of laparoscopic gynecologic procedures are able to prevent postoperative pain at wake-up and during the first 24 h. A total of 180 patients were randomly assigned into three groups to receive an intraperitoneal instillation of 20 mL of either bupivacaine 0.5% (Group B), ropivacaine 0.75% (Group R) or saline (Group S) at the end of surgery. All patients received analgesia with acetaminophen and ketoprofen IV infusions. Pain was assessed by using a 010 graded numerical scale (NS) every 5 min in the postanesthesia care unit and IV morphine was administered if NS was >4. Assessment of pain was continued every 4 h on the ward, and subcutaneous morphine was injected if needed to keep the NS score < 4. Postoperative nausea and vomiting (PONV) was rated on a 4-point scale. The morphine consumption at wake-up and over the first 24 h was significantly lower (P < 0.05) in Group B (mean, 0.92 mg at wake-up; 3.08 mg over 24 h) and in Group R (mean, 0.25 mg at wake-up; 0.69 mg over 24 h), than in Group S (mean, 4.18 mg at wake-up; 12.93 mg over 24 h). The morphine-sparing effect of ropivacaine was significantly greater than that of bupivacaine. Both local anesthetics were effective in the prevention of PONV. We concluded that local anesthetics should be instilled in all gynecologic patients at the end of all laparoscopic procedures.
Implications: Local anesthetic instillation (ropivacaine rather than bupivacaine) at the end of laparoscopy prevents postoperative pain and dramatically decreases the need for morphine. This technique, compared with placebo, is safe, improves patient comfort, shortens the stay in the postoperative care unit and decreases nursing care in the ward.
This article has been cited by other articles:
![]() |
Y. Demiraran, O. Ozturk, E. Guclu, A. Iskender, M. H. Ergin, and A. Tokmak Vasoconstriction and Analgesic Efficacy of Locally Infiltrated Levobupivacaine for Nasal Surgery Anesth. Analg., March 1, 2008; 106(3): 1008 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Paech, K. F. Ilett, L. P. Hackett, M. Page-Sharp, and R. W. Parsons Disposition and Clinical Outcome After Intraperitoneal Meperidine and Ropivacaine Administration During Laparoscopic Surgery Anesth. Analg., January 1, 2008; 106(1): 278 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ng and G. Smith Editorial I: Intraperitoneal administration of analgesia: is this practice of any utility? Br. J. Anaesth., October 1, 2002; 89(4): 535 - 537. [Full Text] [PDF] |
||||
|